Chromatography
Launch of Ready-to-Use Ninhydrin Formulation for Ion Exchange Chromatography Systems
Mar 26 2014
Biochrom Ltd, a manufacturer of quality scientific instruments for applications in the life science, clinical, and analytical markets, announced today the commercial launch of its EZ Nin ReagentTM, a ready-to-use ninhydrin formulation for use in ion exchange chromatography systems with post-column derivatisation for improved amino acid analysis.
The newly launched and patent protected EZ Nin Reagent has been developed to save laboratory time and waste; it requires no mixing or nitrogen and does not degrade with time or exposure to oxygen, providing reliable analysis over time without loss of sensitivity. Challenges encountered with standard ninhydrin include the long preparation process, instability of the reagent, degradation and waste, and batch-to-batch variability. Each batch of EZ Nin Reagent is identically prepared, enabling the reagent to be topped up on the instrument, eliminating waste or the risk of running out during a series of analyses. EZ Nin Reagent is methanol and hydrindantin free.
Tristana von Will, Product Marketing Manager at Biochrom, commented: “Biochrom’s formulation combines ease of use with unprecedented chemical stability, providing laboratories with the confidence they require when evaluating concentrations of amino acids for diagnosis and monitoring of inborn errors of metabolism (IEMs).”
To pre-order your free trial pack of EZ Nin reagent, please register at: http://eznin.biochrom.co.uk. An application note demonstrating the stability and accuracy of EZ Nin is also available on the microsite.
CMS
Biochrom
Tristana von Will
Biochrom Ltd
Digital Edition
LMUK 49.7 Nov 2024
November 2024
Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Handling - Clinical, Medical & Diagnostic Products News...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan